QS21

BIOLOGICAL15 trials

Sponsors

University of Virginia, Memorial Sloan Kettering Cancer Center, European Organisation for Research and Treatment of Cancer - EORTC, Fox Chase Cancer Center, Ohio State University Comprehensive Cancer Center

Conditions

Breast CancerCancerChronic Kidney Disease, Stage 4Chronic Kidney Disease, Stage 5Colorectal CancerEBV-Related Lymphoproliferative DisorderEBV-Related Malignant NeoplasmFallopian Tube Cancer

Phase 1

Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer

CompletedNCT00036933

Memorial Sloan Kettering Cancer CenterProstate Cancer

Start: 2002-03-31End: 2009-03-31Updated: 2013-03-25

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

CompletedNCT00003819

Memorial Sloan Kettering Cancer CenterProstate Cancer

Start: 1998-06-30End: 2009-03-31Updated: 2013-03-19

Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

CompletedNCT00006387

Fox Chase Cancer CenterColorectal Cancer, Pancreatic Cancer

Start: 2000-10-31End: 2002-01-31Updated: 2013-07-11

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

CompletedNCT00004929

Memorial Sloan Kettering Cancer CenterProstate Cancer

Start: 1999-09-30End: 2008-06-30Updated: 2013-01-31

Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

CompletedNCT00006041

Memorial Sloan Kettering Cancer CenterFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2000-02-29End: 2002-02-28Updated: 2013-06-19

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

CompletedNCT00003357

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 1998-01-31End: 2001-11-30Target: 9Updated: 2012-12-13

Vaccine Therapy in Treating Patients With Metastatic Melanoma

CompletedNCT00003224

University of VirginiaMelanoma (Skin)

Start: 1996-02-29Updated: 2014-11-20

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

SuspendedNCT06741072

Ohio State University Comprehensive Cancer CenterChronic Kidney Disease, Stage 4, Chronic Kidney Disease, Stage 5, EBV-Related Lymphoproliferative Disorder +2

Start: 2026-03-01End: 2027-12-31Target: 55Updated: 2026-01-08

Phase 2

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

CompletedNCT00004052

Memorial Sloan Kettering Cancer CenterLeukemia

Start: 1999-03-31End: 2005-08-31Target: 24Updated: 2013-06-25

Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

CompletedNCT00004249

Memorial Sloan Kettering Cancer CenterLung Cancer

Start: 1998-08-31End: 2001-11-30Updated: 2013-06-19

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

CompletedNCT00003362

Memorial Sloan Kettering Cancer CenterMelanoma (Skin)

Start: 1998-05-31End: 2001-02-28Updated: 2013-06-25

Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

CompletedNCT00579423

Memorial Sloan Kettering Cancer CenterCancer, Prostate

Start: 2000-11-30End: 2009-03-31Updated: 2023-10-05

Phase 3

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

European Organisation for Research and Treatment of Cancer - EORTCMelanoma (Skin)

Start: 1999-12-31Updated: 2009-02-09

Unknown Phase

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

CompletedNCT00030823

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 2001-03-31End: 2009-02-28Updated: 2015-12-30

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

CompletedNCT00470574

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 2007-03-20End: 2020-01-24Updated: 2020-11-18

Related Papers

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).

2011-05-18142 citations